Tumor-associated macrophage (TAM)-secreted CCL22 confers cisplatin resistance of esophageal squamous cell carcinoma (ESCC) cells via regulating the activity of diacylglycerol kinase α (DGKα)/NOX4 axis
- Resource Type
- Article
- Source
- In
Drug Resistance Updates March 2024 73 - Subject
- Language
- ISSN
- 1368-7646